Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inpatient treatment of persistent somatization.

E Shorter1, S E Abbey, L A Gillies

  • 1History of Medicine Program, Faculty of Medicine, University of Toronto, Ontario, Canada.

Psychosomatics
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does persisting fear sustain catatonia?

Acta psychiatrica Scandinavica·2017
Same author

Case of delirious mania in Charles VI.

Acta psychiatrica Scandinavica·2015
Same author

Catatonia is a systemic medical syndrome.

Acta psychiatrica Scandinavica·2015
Same author

The potential role of electroconvulsive therapy in the 'Iron Triangle' of pediatric catatonia, autism, and psychosis.

Acta psychiatrica Scandinavica·2013
Same author

Childhood catatonia, autism and psychosis past and present: is there an 'iron triangle'?

Acta psychiatrica Scandinavica·2013
Same author

Effect of dietary omega-3 fatty acids on red blood cell lipid composition and plasma metabolites in the cockatiel, Nymphicus hollandicus.

Journal of animal science·2012

Persistent somatization in patients presents clinical challenges. Mood is key to subgrouping somatizing patients, with nondepressed individuals often showing early-onset chronic illness and poor treatment response.

Area of Science:

  • Psychosomatic Medicine
  • Clinical Psychology
  • Internal Medicine

Background:

  • Persistent somatization is a complex condition challenging clinical management.
  • Inpatient psychosomatic units manage patients with disabling somatization symptoms.

Purpose of the Study:

  • To identify clinically significant subgroups among patients with persistent somatization.
  • To explore predictors of treatment outcome in this patient population.

Main Methods:

  • Retrospective analysis of 92 patients treated on an inpatient psychosomatic medicine unit.
  • Subgrouping based on the presence or absence of mood disturbance.
  • Correlation of clinical factors with symptom presentation and treatment response.

Main Results:

Related Experiment Videos

  • Mood was the most significant factor differentiating somatizing patient subgroups.
  • Nondepressed somatizing patients exhibited early-onset chronic illnesses.
  • Nondepressed patients' symptoms were less correlated with stressors and showed poor treatment responsiveness.
  • Symptom duration, mood disturbance, and stable relationships predicted treatment outcome.

Conclusions:

  • Mood is a critical differentiator for somatizing patients, impacting illness course and treatment.
  • Nondepressed somatizing patients represent a distinct subgroup with poorer prognosis.
  • Targeted interventions considering mood and symptom duration may improve outcomes.